Journal of Public Health Policy

, Volume 34, Issue 1, pp 22–30

When falsified medicines enter the supply chain: Description of an incident in Kenya and lessons learned for rapid response

  • Jennifer Cohn
  • Tido von Schoen-Angerer
  • Elodie Jambert
  • Guido Arreghini
  • Michelle Childs
Original Article

DOI: 10.1057/jphp.2012.53

Cite this article as:
Cohn, J., von Schoen-Angerer, T., Jambert, E. et al. J Public Health Pol (2013) 34: 22. doi:10.1057/jphp.2012.53

Abstract

Falsified and substandard medicines present serious concerns for public health. We describe an event that occurred in late 2011 involving falsified antiretroviral medicines found in the supplies of Médecins Sans Frontières (MSF) projects in Kenya. We discuss factors contributing to these falsified medicines entering the supply chain as well as the response by MSF and others. We make recommendations to help defend against future episodes of entry of falsified medicines into the supply chain as well as comments on appropriate responses in cases of falsified medicines.

Keywords

falsified medicine antiretroviral therapy pharmacovigilance Kenya 

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2012

Authors and Affiliations

  • Jennifer Cohn
    • 1
  • Tido von Schoen-Angerer
    • 2
  • Elodie Jambert
    • 2
  • Guido Arreghini
    • 3
  • Michelle Childs
    • 2
  1. 1.University School of Medicine, University of PennsylvaniaPhiladelphiaUSA
  2. 2.Médecins Sans FrontièresGeneva,Switzerland
  3. 3.Médecins Sans FrontièresNairobiKenya

Personalised recommendations